Next-generation upgrade strengthens data comparability and compliance—without changing trusted instrumentation San Jose – Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, today announced the launch of Vi-CELL BLU 2.0 Viability Analyzer Software, a major upgrade that enables laboratories to modernize cell viability workflows while maintaining data continuity, […]

Acquisition adds regulated bioanalytical and CMC services, diagnostic reagents, and workflow critical products to support translational, clinical, and commercial development SHAKER HEIGHTS, Ohio — VION Biosciences (“VION”), a life sciences company building integrated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Prolytix, a provider of regulated bioanalytical […]

Acquisition strengthens Revvity’s position in human-relevant life sciences tools for next-generation GLP-1 and GPCR-targeting therapies for metabolic drug discovery Combines HCD’s human pancreatic beta cell models with Revvity’s capabilities in cell analysis, detection, high-content screening and gene editing Expands Revvity’s ability to support customers across the research-to-clinic continuum, including emerging applications in clinical development and […]

In the news release, Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing, issued 09-Sep-2026 by Partillion Bioscience over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Tenth SBIR award brings Partillion’s total non-dilutive […]

WALTHAM, Mass. — NanoMosaic, a pioneer in multiomic analytical technologies for cell and gene therapy development and manufacturing, today announced its participation in a multidisciplinary team awarded up to $39.2 million by the Advanced Research Projects Agency for Health (ARPA-H). Led by investigators at the Mass General Brigham Gene and Cell Therapy Institute and Massachusetts […]

VIENNA — Cell-free DNA assembly pioneer, Ribbon Bio, has today announced the appointment of Jay Therrien as Chief Business Officer. Therrien joins Ribbon’s executive leadership team where he will lead the company’s commercial strategy and growth initiatives. Therrien brings over two decades of experience building and leading commercial organizations across the life sciences and genomics […]

LOS ANGELES — Molecular Instruments® (MI), founded by the inventor of HCR™ technology, today announced the availability of HCR™ Gold IF on Biocare Medical’s ONCORE Pro X, a fully open automated slide staining system for research laboratories. Powered by the HCR™ HiFi Encoder, HCR™ Gold IF lets researchers build multiplex immunofluorescence assays with any off-the-shelf […]

SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company’s board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of service as a director. Koh joined Agilent’s board in 2003 and served as independent chair from 2017 until […]

YANTAI, China — CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certification for Pharmaceutical Auxiliary Materials (PAMs), becoming the first Chinese cell culture media supplier to receive EXCiPACT™ certification. EXCiPACT™ is an internationally recognized certification scheme for pharmaceutical auxiliary materials, establishing GMP requirements for materials used in biopharmaceutical […]

Shelton, CT – PerkinElmer, a global leader in analytical solutions and specialized services for the life sciences, applied, and food markets, today announced the completion of its acquisition of SimoTech, a trusted provider of manufacturing automation and GMP IT solutions to the life sciences industry, following the company’s announcement of the signed transaction on August […]